1. TP53INP2 Modulates Epithelial-to-Mesenchymal Transition via the GSK-3β/β-Catenin/Snail1 Pathway in Bladder Cancer Cells


    Zhengtao Zhou et al, 2020, OncoTargets and Therapy CrossRef
  2. Antifungal immunity mediated by C-type lectin receptors may be a novel target in immunotherapy for urothelial bladder cancer
    Tianhang Li et al, 2022, Frontiers in Immunology CrossRef
  3. Identification of vital prognostic genes related to tumor microenvironment in pheochromocytoma and paraganglioma based on weighted gene co-expression network analysis
    Chun-Xian Chen et al, 2021, Aging CrossRef
  4. Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis
    Xutengyue Tian et al, 2022, Journal of Oncology CrossRef
  5. Clinical and prognostic significance of CC chemokine receptor type 8 protein expression in gastrointestinal stromal tumors
    Huai-Liang Li et al, 2020, World Journal of Gastroenterology CrossRef
  6. Chemokines as the critical factors during bladder cancer progression: an overview
    Amir Sadra Zangouei et al, 2021, International Reviews of Immunology CrossRef
  7. Development of an Immunogenomic Landscape-Based Prognostic Index of Head and Neck Squamous Cell Carcinoma
    Jinhua Long et al, 2020, Frontiers in Molecular Biosciences CrossRef
  8. Exosome-Transmitted miR-128 Targets CCL18 to Inhibit the Proliferation and Metastasis of Urothelial Carcinoma
    Donghao Shang et al, 2022, Frontiers in Molecular Biosciences CrossRef
  9. Downregulation of HMGA1 Mediates Autophagy and Inhibits Migration and Invasion in Bladder Cancer via miRNA-221/TP53INP1/p-ERK Axis
    Xiaoqiang Liu et al, 2020, Frontiers in Oncology CrossRef